Corbus Pharmaceuticals Holdings, Inc. Debt Instrument, Interest Rate, Stated Percentage
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Debt Instrument, Interest Rate, Stated Percentage of 3.25% as of 2014-10-31, per its 10-Q filed 2015-11-10.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2015-11-10
- 2014-10-31: Debt Instrument, Interest Rate, Stated Percentage 3.25%.
- 2013-12-31: Debt Instrument, Interest Rate, Stated Percentage 7.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2014-10-31 | 3.25% 10-Q · filed 2015-11-10 |
| 2013-12-31 | 7.00% 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |